Steph & CO Horizon Therapeutics Public LTD CO Transaction History

Steph & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$107.32 - $113.5 $86,929 - $91,935	-810 Reduced 71.05%	330 $36,000
Q4 2022 Jan 26, 2023	SELL	$62.39 - $113.8 $62,390 - $113,800	-1,000 Reduced 46.73%	1,140 $130,000
Q3 2022 Oct 11, 2022	BUY	$58.92 - $84.67 $4,536 - $6,519	77 Added 3.73%	2,140 $132,000
Q2 2022 Jul 13, 2022	BUY	$79.4 - $116.36 $20,882 - $30,602	263 Added 14.61%	2,063 $165,000
Q1 2022 Apr 15, 2022	BUY	$86.42 - $109.81 $32,926 - $41,837	381 Added 26.85%	1,800 $189,000
Q2 2021 Jul 27, 2021	BUY	$86.24 - $95.92 $39,066 - $43,451	453 Added 46.89%	1,419 $133,000
Q1 2021 Apr 16, 2021	BUY	$71.83 - $95.48 $11,708 - $15,563	163 Added 20.3%	966 $89,000
Q4 2020 Jan 29, 2021	BUY	$67.0 - $84.39 $53,801 - $67,765	803 New	803 $59,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

Stay updated on Steph & CO with notifications on news.